Hesperian released a Coronavirus (COVID-19) Fact Sheet specifically for people like you, individuals and organizations seeking credible resources. Thanks to the incredible skill and participation of many partners on short notice, it is available now in English, Spanish, French, Chinese, Urdu, Bangla..., Filipino, Vietnamese, Bahasa Indonesia, Farsi, Sindhi, Telugu, and Hindi on the website. Fact sheets in Shona, Portuguese, Arabic, and Chichewa are on the way.
more
CORONAVIRUS COVID-19 INFORMAÇÕES E ORIENTAÇÕES
Countries who have no testing capacity and national COVID-19 laboratories with limited experience on COVID-19 virus testing are encouraged to send the first five positives and the first ten negative COVID-19 samples to WHO reference laboratories providing confirmatory testing for COVID-19.
Updates ...29 April 2020
more
NICE Scientific Advice is providing free fast track advice for researchers who are developing novel diagnostics or therapeutics for COVID-19. The team is working to help researchers from around the world optimise their approach to generating the essential evidence required for health technology ass...essments, which inform decision making.
more
Bioforce launches today "STOP COVID-19 - Essentials for the prevention and control of the virus", a freely accessible, on-line, succint and practical, self learning tool in French, aimed at national and international actors deployed for the prevention and control of the virus in local communities wh...ere confinement is particularly difficult.
more
Contact tracing is a core public health response to COVID-19.Other measures include active case finding or physical distancing. In order to trace a contact, we first need to define what a ‘contact’ is.
22 July 2022. This document summarizes current WHO guidance for public health surveillance of coronavirus disease 2019 (COVID-19) in humans caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
The COVID-19 pandemic affects older people disproportionately, especially those living in long-term care facilities (LTCF) with significant impact on mortality and morbidity. Concerted action is needed to mitigate the impact of COVID-19 by enhancing infection prevention and control (IPC) measures wi...thin LTCF. The COVID-19 IPC course for LTCF consists of 4 training modules to be used in conjunction with the LTCF communication toolkit and preparedness checklist. This package is tailored for LTCF and based on WHO's in-depth technical guidance on IPC.
This course is also available in the following languages: Bahasa Indonesia - Nederlans
more
Getting story ideas right -- Getting your sources right -- Getting your facts right -- Getting your report right -- Getting images and videos verified accurately -- Getting maps right -- Getting your language right
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method...ology issues there are still insufficient data to make a recommendation, in which case different options for approaching VE evaluations are presented.
more
3 March 2022
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an ...online platform, and is updated regularly as new evidence emerges.
more
New funding requirements: CHF 2.8 billion IFRC-wide of which CHF 670 million is channelled through the IFRC Emergency Appeal in support of National Societies
scientific brief, 2 March 2022
– (Comirnaty® 10 мкг або 30 мкг виробництва BioNTech/Pfizer та
AUFKLÄRUNGSMERKBLATT
Zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019) (Grundimmunisierung und Auffrischimpfungen)
– mit mRNA-Impfstoffen –
(Comirnaty® 10 μg bzw. 30 μg von BioNTech/Pfizer... und Spikevax® von Moderna)
more
(Первинна та бустерна вакцинації) – з векторною вакциною – (вакцина Janssen® від COVID-19 виробництва Janssen Cilag International/Johnson & Johnson
Станом на: 14 лютого 2022 р. (даний інформаційн...й лист постійно оновлюється)
AUFKLÄRUNGSMERKBLATT
Zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019)
(Grundimmunisierung und Auffrischimpfungen) – mit Vektor-Impfstoff – (COVID-19 Vaccine Janssen® von Janssen Cilag International/Johnson & Johnson)
Stand: 14. Februar 2022 (dieses Aufklärungsmerkblatt wird laufend aktualisiert)
more
Tuberculosis (TB) is the deadliest infectious disease in most low- and middle-income countries, claiming more than 4,000 lives each day. The unprecedented COVID-19 pandemic has seriously impacted people with pre-existing health conditions. People with TB are usually more vulnerable to other infectio...ns, including the novel coronavirus, due to pre-existing lung damage. They are also at higher risk of developing complications from COVID-19.
more
The World Health Organization (WHO) recognizes the challenges countries face for maintaining their COVID-19 response while addressing competing public health challenges, conflicts, climate change and economic crises.
It remains critical for national programmes to continue to offer testing for COVI...D-19 in line with three main objectives: reduce morbidity and mortality through linkage to prompt care and treatment, reduce onward transmission and track the evolution of the epidemic and the virus
itself.
more
Update, 23 de junio de 2022
La prévalence de la covid -19 chez la femme enceinte et les accouchées semble être faible. Elles étaient asymptomatiques et le pronostic maternel était satisfaisant. Néanmoins, le risque de for.pdf